$8.34
0.0% Today
as of Oct 22, 16:49 ET
Last 30 days
Recent Press Releases & News
HBIO earnings at a glance
Harvard Bioscience, Inc. (HBIO) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Over its last 4 reports the stock rose the next day 1 time and fell 3, moving ±11.6% on average; after the most recent report on May 12, 2026 it moved -20.9%. HBIO beat the consensus EPS estimate in 1 of its last 1 reported quarters. The share price of $8.34 sits near its 52-week high.
Overview
52-week range
$4.00
$9.40
80% of range
Avg surprise (last 1)
+50.0%
Avg reaction (last 4)
-6.9%
25% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.64 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.39 | — | — | -1,850% | -20.9% | earnings |
| Thu Nov 6, 2025 | Sep/2025 | $-0.01 | — | — | — | -6.8% | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-0.02 | — | — | — | -9.4% | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.02 | $-0.04 | +50.0% | — | +9.4% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.11 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.07 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.11 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.03 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.02 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.01 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Nov 5, 2026 | Sep/2026 | OTHER | — | -$0.10 |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23M | $21M | — | $21M | $20M | $22M | — | $22M |
| Cost of revenue | $10M | $9M | — | $9M | $9M | $10M | — | $9M |
| Gross profit | $13M | $12M | — | $12M | $12M | $12M | — | $13M |
| Operating income | $-978,000 | $-1M | — | $197,000 | $-819,000 | $-50M | — | $-2M |
| Net income | $-3M | $-3M | — | $-1M | $-2M | $-50M | — | $-5M |
| EPS (diluted) | $-0.64 | $-0.77 | — | $-0.03 | $-0.52 | $-11.42 | — | $-0.11 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7M | $7M | $9M | $7M | $7M | $6M | $4M | $5M |
| Inventory | $22M | $22M | $21M | $22M | $22M | $23M | $23M | $26M |
| Total current assets | $46M | $47M | $48M | $44M | $45M | $45M | $45M | $47M |
| Total assets | $76M | $78M | $80M | $78M | $80M | $80M | $127M | $131M |
| Long-term debt | $37M | $36M | $36M | $34M | $35M | $36M | — | $35M |
| Total liabilities | $69M | $68M | $66M | $64M | $64M | $65M | $63M | $66M |
| Total equity | $7M | $10M | $14M | $14M | $16M | $15M | $63M | $65M |
Implied volatility — last 90 days
No IV snapshots yet for HBIO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
HBIO earnings FAQ
When is HBIO's next earnings date?
Harvard Bioscience, Inc. is expected to report on November 5, 2026.
How does HBIO stock usually react to earnings?
Across the last 4 reports the average next-day move was ±11.6%, up 1 times and down 3 times.